SCHEMBL19852014

SCHEMBL19852014

CN1CCCCC(C(=O)OCc2ccccc2)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 6/20 0.54
ALDH1A1 P00352 3/20 0.50
HSD17B10 Q99714 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
GABRA1 P14867 1/20 0.50
GABRG2 P18507 1/20 0.50
GABRB3 P28472 1/20 0.50
GABRA3 P34903 1/20 0.50
GABRA2 P47869 1/20 0.50
GABRB2 P47870 1/20 0.50
CHRNB2 P17787 1/20 0.49
CHRNB4 P30926 1/20 0.49
CHRNA3 P32297 1/20 0.49
CHRNA4 P43681 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
HPGD P15428 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13287235 0.96 ALDH1A1 (0.54) FKBP1AALDH1A1HSD17B10L3MBTL1GABRA1
SCHEMBL23816359 0.91 SMN1; SMN2 (0.55) FKBP1AALDH1A1HSD17B10L3MBTL1GABRA1
SCHEMBL24131982 0.91 SMN1; SMN2 (0.55) FKBP1AALDH1A1HSD17B10L3MBTL1GABRA1
SCHEMBL19625794 0.84 HPGD (0.55) ALDH1A1L3MBTL1HPGDNPC1RAB9A
SCHEMBL2703515 0.83 FABP7 (0.55) FKBP1AALDH1A1L3MBTL1NPC1RAB9A
SCHEMBL13287204 0.82 SMN1; SMN2 (0.57) FKBP1AHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL924014 0.82 GABRA1 (0.53) FKBP1AALDH1A1HSD17B10L3MBTL1GABRA1
SCHEMBL31518977 0.81 FABP7 (0.54) FKBP1AALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL522278 0.81 FABP7 (0.54) FKBP1AALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL10951142 0.81 FKBP1A (0.54) FKBP1AALDH1A1L3MBTL1GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed